Cepheid
The firm's full-year 2024 revenues were essentially flat, with core revenues declining 2 percent.
The firm said preliminary core Q4 2024 revenues are expected to be flat, exceeding prior expectations, while its China business has stabilized and will recover.
Cepheid Tuberculosis Assay Receives WHO Prequalification
The WHO noted that Cepheid's test is the first test for tuberculosis and antibiotic susceptibility testing that meets the prequalification standards.
World Health Organization Adds Cepheid Mpox Tests to Emergency-Use List
The test is among three mpox in vitro diagnostics that have been reviewed and listed by the WHO so far.
Doctors Without Borders Urges Danaher, Cepheid to Further Reduce Price of TB Tests
In an open letter, the organization called on Danaher and its subsidiary Cepheid to further lower the price of its Xpert MTB/RIF Ultra tuberculosis test.
Aug 23, 2024
Apr 25, 2023
Apr 19, 2023
Nov 7, 2022
Cepheid Nabs CE Mark for Group B Strep Test
Jul 25, 2022